glp-1 lawsuit news today Ozempic [July 2026 Update] GLP-1 Receptor Agonists: Drug Litigation

Exercise, protein metabolism, and muscle growth

Administration Mounjaro and Ozempic are both administered as subcutaneous injections once a week

While joint pain relief is not an FDA-approved indication for GLP-1 medications, emerging clinical observations and patient reports have prompted investigation into potential musculoskeletal benefits

J Investig Allergol Clin Immunol 30(5):367369

illegal semaglutide knock-offs or supplements outright claiming to treat obesity)

This is pressuring manufacturers to refine marketing language, substantiation practices, and product-positioning strategies across digital wellness channels